Vatal to form Karnataka Praja Samyukta Ranga, to field candidates in Assembly polls

Bengaluru, Apr 22: In order to infuse confidence among people to fight against the COVID-19 pandemic, Karnataka government on Wednesday launched a helpline 'Apthamitra' with an exclusive toll free number and a mobile app, aimed at providing required medical advice and guidance for those in need.

The help line and app was launched by Chief Minister B S Yediyurappa in the presence of senior Ministers and officials of the department.

Speaking on the occasion, Mr Yediyurappa said that the help line was need at this crucial juncture. “If anyone has symptoms of Coronavirus, they can call the helpline from their home, get medical advice or assistance and get their doubts cleared. 

People who call to know the symptoms, an expert team of doctors will advice on what to do next.”

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi/Mangaluru, Mar 1: A total of twenty leaplings were born in the hospitals of the Udupi and Dakshina Kannada (DK) districts on Saturday, February 29, district health department said on Sunday.

According to the district health department, sixteen babies were born in DK district while Udupi district saw four births. More boys than girls were born in DK (12–4) and it was the inverse in Udupi district (3–1).